EUVIMEDEUVIMED entdecken
Crossref

Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor

Rui Cao iD, Renda Li, Hui Shi, Hongguang Liu iD, Zhen Cheng iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.2c00964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Rui Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang110167, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAnimalsHumansMiceDiagnostic ImagingIndocyanine GreenMolecular Docking SimulationPeptidesErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

HER2NIR-IIoptical imagingpeptidetumor

Substanzen

Indocyanine GreenPeptidesErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang110167, China.
  • State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai264117, Shandong, China.

ORCID-Profile: Rui Cao, Hongguang Liu, Zhen Cheng

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Cao, R., Li, R., Shi, H., Liu, H., & Cheng, Z. (2023). Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00964

Vancouver

Cao R, Li R, Shi H, Liu H, Cheng Z. Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00964

BibTeX
@article{Cao2023,
  author = {Cao, Rui and Li, Renda and Shi, Hui and Liu, Hongguang and Cheng, Zhen},
  title = {Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.2c00964}
}
Kostenlos starten →